ANTI-TOXOPLASMA GONDII ANTIBODIES IN EGYPTIAN PATIENTS WITH SCHIZOPHRENIA
DOI:
https://doi.org/10.61841/t7c0fy22Abstract
For nearly 100 years, infectious microbes dominated discourse on the causes of schizophrenia, Toxoplasma gondii is an obligate intracellular parasite and is found in 2 forms in humans. Toxoplasma gondii has been associated with several congenital CNS anomalies and more subtle delayed neurologic sequelae, The evidence of infection as a cause of schizophrenia was supported by the brain histopathological changes found in patients with schizophrenia, the risk of schizophrenia increased among individuals who were exposed in utero to elevated maternal T. gondii immunoglobin G (IgG) antibody, based on assay of archived maternal sera, was more than twice that of comparison subject, The main aim of this study was to compare the prevalence of T. gondii infection between individuals with schizophrenia and healthy controls in Egyptian choret samples.
100 patients with schizophrenia, and 100 healthy donors where screened for Toxoplasma gondii IgG and IgM antibodies in serum by ELISA.
A significant increase in the incidence of Toxoplasma gondii IgG positive antibody in patient group compared to control group (P 0.004)
References
Brown, A.S., Response to Vedeniapin Letter. American Journal of Psychiatry, 2010. 167(10): p. 1276-1276.
Cotter, D.R., C.M. Pariante, and I.P. Everall, Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain research bulletin, 2001. 55(5): p. 585-595.
Horacek, J., et al., Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls: voxel-based-morphometry (VBM) study. The World Journal of Biological Psychiatry, 2012. 13(7): p. 501-509.
Creese, I., et al., Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Journal of Neuropsychiatry and Clinical Neurosciences, 1996. 8(2): p. 222-226.
Richtand, N.M., et al., Dopamine and serotonin receptor binding and antipsychotic efficacy. Neuropsychopharmacology, 2007. 32(8): p. 1715-1726.
Jones-Brando, L., E.F. Torrey, and R. Yolken, Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophrenia research, 2003. 62(3): p. 237-244.
Webster, J., et al., Parasites as causative agents of human affective disorders The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proceedings of the Royal Society of London B: Biological Sciences, 2006. 273(1589): p. 1023-1030.
Stibbs, H., Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Annals of tropical medicine and parasitology, 1985. 79(2): p. 153-157.
Xiao, J., et al., MicroRNA-132 dysregulation in Toxoplasma gondii infection has implications for dopamine signaling pathway. Neuroscience, 2014. 268: p. 128-138.
Torrey, E.F. and R.H. Yolken, Toxoplasma gondii and schizophrenia. Emerging infectious diseases, 2003. 9(11): p. 1375.
Wang, T., et al., A potential association between Toxoplasma gondii infection and schizophrenia in mouse models. Experimental parasitology, 2013. 135(3): p. 497-502.
Wang, H.-L., et al., The effect of artemether on psychotic symptoms and cognitive impairment in first-episode, antipsychotic drug-naive persons with schizophrenia seropositive to Toxoplasma gondii. Journal of psychiatric research, 2014. 53: p. 119-124.
Hamidinejat, H., et al., Toxoplasma gondii infection in first-episode and inpatient individuals with schizophrenia. International journal of infectious diseases, 2010. 14(11): p. e978-e981.
Garcia, S. and A. Bruckner, Tissue protozoa (Toxoplasma gondii). Diagnostic medical parasitology, 1997: p. 111-121.
Cetinkaya, Z., et al., Anti-Toxoplasma gondii antibodies in patients with schizophrenia preliminary findings in a Turkish sample. Schizophrenia bulletin, 2007. 33(3): p. 789-791.
Palazzi, D., J. Klein, and C. Baker, Bacterial sepsis and meningitis. Infectious Diseases of the Fetus and Newborn Infants. 6th ed. USA: Elsevier Saunders, 2006: p. 247-95.
Brown, A.S., et al., Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. American Journal of Psychiatry, 2005. 162(4): p. 767-773.
Omar, A., et al., Seropositivity and Serointensity of Toxoplasma gondii Antibodies and DNA among Patients with Schizophrenia. The Korean journal of parasitology, 2015. 53(1): p. 29.
Melzer, T., et al., Host cell preference of Toxoplasma gondii cysts in murine brain: a confocal study. Journal of neuroparasitology, 2010. 1.
Ho, Y.-C., et al., Clinical presentation and outcome of toxoplasmic encephalitis in patients with human immunodeficiency virus type 1 infection. Journal of microbiology, immunology, and infection Wei mian yu gan ran za zhi, 2008. 41(5): p. 386-392.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Journal of Advance Research in Pharmacy and Biological Science (ISSN 2208-2360)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Terms & Condition
Submission -
Author can submit the manuscript through our online submission process or email us at the designated email id in contact details.
The other mode of submission not accepted than online and email.
Before submission please read the submission guidelines.
NN Publication accepts only article submitted in pdf/doc/docx/rtf file format. Another format except given file formats will no be considered .
Author will be responsible for the error mistakes in the submission files. The minor changes can be done without any cost after publication. But for major changes NN Publication may charges you the editing charges.
Publication (Online) -
The online publication is scheduled on last date of every month, but it can be delayed by 24 to 48 hours due to editorial process if huge number of articles comes to publish in single issue.
Automatic notificatation email will be sent to the all users on publication of an issue, so its author’s duty to check their email inbox or SPAM folder to get this notification.
After publication of article author can not withdraw their article.
If editor’s found any issue after publication of article then the NN Publication have the authority to remove the article from online website.
No refund will be provided after online publication of article.
Publication (Print) -
The print copy publication are sent as per the author’s request after 2 weeks of online publication of that issue.
NN Publication will ship the article by India Post and provide the consignment number on dispatch of print copy.
NN Publication follows all the guidelines of delivery provided by IndiaPost and hence not responsible for delay in delivery due to any kind of reasons.
Refund of hard copy will not be provided after dispatch or print of the journal.
NN Publication will be responsible for raise a complain if there is any issue occurs in delivery, but still will not be responsible for providing the refund.
NN Publication will be responsible to resend the print copy only and only if the print copy is lost or print copy is damaged in delivery / or there is delay more than 6 months.
According to India Post the delivery should be completed with in 1-3 weeks after dispatch of articles.
Privacy Policy-
NN Publication uses the email ids of authors and editors and readers for sending editorial or publication notification only, we do not reveal or sell the email ids to any other website or company.
